eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:05
eXoZymes Price : 4.30 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 4.604 | 4.890 | 4.11 | 4.11 | 7359.00 |
| Nov 04, 2026 | 4.80 | 4.80 | 4.30 | 4.31 | 12417.00 |
| Nov 03, 2026 | 4.32 | 4.835 | 4.32 | 4.75 | 2632.00 |
| Nov 02, 2026 | 4.29 | 4.59 | 4.15 | 4.52 | 2600.00 |
| Oct 30, 2026 | 4.18 | 4.19 | 4.01 | 4.13 | 6113.00 |
| Oct 29, 2026 | 4.30 | 4.31 | 4.00 | 4.11 | 9232.00 |
| Oct 28, 2026 | 3.74 | 4.57 | 3.682 | 4.225 | 16747.00 |
| Oct 27, 2026 | 3.79 | 4.046 | 3.24 | 3.80 | 16652.00 |
| Oct 26, 2026 | 4.00 | 4.40 | 3.75 | 3.75 | 16573.00 |
| Oct 23, 2026 | 3.88 | 4.44 | 3.85 | 4.00 | 14308.00 |
| Oct 22, 2026 | 3.80 | 4.64 | 3.80 | 3.90 | 26491.00 |
| Oct 21, 2026 | 4.15 | 4.70 | 3.92 | 3.92 | 19967.00 |
| Oct 20, 2026 | 4.200 | 4.435 | 4.03 | 4.12 | 4313.00 |
| Oct 19, 2026 | 4.298 | 4.52 | 3.85 | 4.00 | 8837.00 |
| Oct 16, 2026 | 4.085 | 4.96 | 4.02 | 4.09 | 32093.00 |
| Oct 15, 2026 | 4.60 | 4.881 | 3.705 | 4.00 | 24355.00 |
| Oct 14, 2026 | 4.51 | 4.80 | 4.51 | 4.60 | 7587.00 |
| Oct 13, 2026 | 5.048 | 5.075 | 4.55 | 4.59 | 20581.00 |
| Oct 12, 2026 | 5.30 | 5.30 | 5.05 | 5.05 | 9391.00 |
| Oct 09, 2026 | 5.335 | 5.41 | 5.25 | 5.25 | 1025.00 |
| Oct 08, 2026 | 5.69 | 6.34 | 5.27 | 5.27 | 22334.00 |
| Oct 07, 2026 | 5.55 | 5.71 | 5.52 | 5.54 | 7551.00 |
| Oct 06, 2026 | 5.64 | 5.72 | 5.52 | 5.52 | 1832.00 |
| Oct 05, 2026 | 5.85 | 5.85 | 5.51 | 5.52 | 4451.00 |
| Oct 02, 2026 | 5.87 | 6.00 | 5.762 | 5.77 | 2116.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 16.80 |
| Perspective Therapeutics, Inc. | 0.9059 |
| MiMedx Group, Inc. | 3.32 |
| ABVC BioPharma, Inc. | 0.9561 |
| Endonovo Therapeutics, Inc. | 0.0001 |
Price Related Metrics
| PEG Ratio | -0.1653 |
| Price to Book Value | 10.92 |
| Earnings Yield | -27.95% |
| Market Cap | 39.91M |
| PEGY Ratio | -0.1653 |